A Cationic Amphiphilic Random Copolymer with pH-Responsive Activity against Methicillin-Resistant Staphylococcus aureus

PLoS One. 2017 Jan 6;12(1):e0169262. doi: 10.1371/journal.pone.0169262. eCollection 2017.

Abstract

In this report, we demonstrate the pH-dependent, in vitro antimicrobial activity of a cationic, amphiphilic random copolymer against clinical isolates of drug-resistant Staphylococcus aureus. The polymer was developed toward a long-term goal of potential utility in the treatment of skin infections. The proposed mechanism of action of the polymer is through selectively binding to bacterial membranes and subsequent disruption of the membrane structure/integrity, ultimately resulting in bacterial cell death. The polymer showed bactericidal activity against clinical isolates of methicillin-resistant or vancomycin-intermediate S. aureus. The polymer was effective in killing S. aureus at neutral pH, but inactive under acidic conditions (pH 5.5). The polymer did not exhibit any significant hemolytic activity against human red blood cells or display cytotoxicity to human dermal fibroblasts over a range of pH values (5.5-7.4). These results indicate that the polymer activity was selective against bacteria over human cells. Using this polymer, we propose a new potential strategy for treatment of skin infections using the pH-sensitive antimicrobial polymer agent that would selectively target infections at pH-neutral wound sites, but not the acidic, healthy skin.

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology*
  • Cells, Cultured
  • Erythrocytes / drug effects
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • Hemolysis / drug effects
  • Humans
  • Hydrogen-Ion Concentration
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Microbial Sensitivity Tests
  • Mupirocin / pharmacology
  • Polymers / adverse effects
  • Polymers / chemistry
  • Polymers / pharmacology
  • Staphylococcus aureus / drug effects
  • Vancomycin / pharmacology

Substances

  • Anti-Bacterial Agents
  • Polymers
  • Vancomycin
  • Mupirocin

Grants and funding

The authors wish to acknowledge the financial support of the Catholic Medical Center Research Foundation made in the program year of 2016 (to SH). This study was also supported by The Catholic University of Korea Daejeon St. Mary's Hospital, Clinical Research Institute Grant (CMCDJ-A-2016-006 to SH) funded by The Catholic University of Korea Daejeon St. Mary's Hospital. We thank the National Science Foundation for NSF CAREER Award (DMR-0845592 to K.K.) and the Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan for financial support. This work was also supported by JSPS Postdoctoral Fellowships for Research Abroad (No. 26-774 to H.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.